Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H21N5O3S |
Molecular Weight | 387.456 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1N(CCCN2CCN(CC2)C3=NC=CC=N3)S(=O)(=O)C4=CC=CC=C14
InChI
InChIKey=MPLTZRTXQLNGED-UHFFFAOYSA-N
InChI=1S/C18H21N5O3S/c24-17-15-5-1-2-6-16(15)27(25,26)23(17)10-4-9-21-11-13-22(14-12-21)18-19-7-3-8-20-18/h1-3,5-8H,4,9-14H2
Molecular Formula | C18H21N5O3S |
Molecular Weight | 387.456 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2149168
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2149168
Revospirone (BAY VQ 7813) is a pyrimidinylpiperazine derivative that acts as partial agonist at 5-HT1A receptors. Head shakes were reported after administration of revospirone in pigs, and once daily administration for 3-5 days led to a reduction in this head shake response. No behavioral alterations were observed. This compound was never marketed
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P08908 Gene ID: 3350.0 Gene Symbol: HTR1A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2149168 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:55:50 GMT 2023
by
admin
on
Sat Dec 16 15:55:50 GMT 2023
|
Record UNII |
6X8764TW2J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2107024
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY | |||
|
95847-87-3
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY | |||
|
72024
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY | |||
|
Revospirone
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY | |||
|
DTXSID10241982
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY | |||
|
6434
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY | |||
|
C76509
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY | |||
|
100000080556
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY | |||
|
6X8764TW2J
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY | |||
|
SUB10296MIG
Created by
admin on Sat Dec 16 15:55:50 GMT 2023 , Edited by admin on Sat Dec 16 15:55:50 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |